Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study).

Saved in:
Bibliographic Details
Title: Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study).
Authors: Vera P; Department of Nuclear Medicine, Henri Becquerel Cancer Center and Rouen University Hospital & QuantIF-LITIS, University of Rouen, Rouen, France pierre.vera@chb.unicancer.fr., Thureau S; Department of Radiation Oncology and Medical Physics, Henri Becquerel Cancer Center and Rouen University Hospital & QuantIF-LITIS, Rouen, France., Chaumet-Riffaud P; Department of Nuclear Medicine, Hôpitaux universitaires Paris Sud Bicêtre AP-HP and University Paris Sud, Paris, France., Modzelewski R; Department of Nuclear Medicine, Henri Becquerel Cancer Center and Rouen University Hospital & QuantIF-LITIS, University of Rouen, Rouen, France., Bohn P; Department of Nuclear Medicine, Henri Becquerel Cancer Center and Rouen University Hospital & QuantIF-LITIS, University of Rouen, Rouen, France., Vermandel M; University Lille, Inserm, CHU Lille, U1189-ONCO-THAI-Image Assisted Laser Therapy for Oncology, Lille, France., Hapdey S; Department of Nuclear Medicine, Henri Becquerel Cancer Center and Rouen University Hospital & QuantIF-LITIS, University of Rouen, Rouen, France., Pallardy A; Department of Nuclear Medicine, Nantes University Hospital, Nantes, France., Mahé MA; Department of Radiation Oncology, Institut de Cancérologie de l'Ouest (ICO)-René Gauducheau, Nantes, France., Lacombe M; Department of Nuclear Medicine, Institut de Cancérologie de l'Ouest (ICO), Nantes, France., Boisselier P; Department of Radiation Oncology, Institut régional du Cancer Montpellier (ICM), Montpellier, France., Guillemard S; Department of Nuclear Medicine, Institut régional du Cancer Montpellier (ICM), Montpellier, France., Olivier P; Department of Nuclear Medicine, Brabois University Hospital, Nancy, France., Beckendorf V; Department of Radiation Oncology, Institut de Cancérologie de Lorraine, Nancy, France., Salem N; Department of Radiation Oncology, Institut Paoli Calmette, Marseille, France., Charrier N; Department of Nuclear Medicine, Institut Paoli Calmette, Marseille, France., Chajon E; Department of Radiation Oncology, Centre regional de lutte contre le cancer de Bretagne Eugène Marquis, Rennes, France., Devillers A; Department of Nuclear Medicine, Centre regional de lutte contre le cancer de Bretagne Eugène Marquis, Rennes, France., Aide N; Nicolas Aide, Nuclear Medicine and TEP Centre, Caen University Hospital and Inserm U1086 ANTICIPE, Caen, France., Danhier S; Department of Radiation Oncology, François Baclesse Cancer Center, Caen, France., Denis F; Department of Radiation Oncology, Institut Inter-Régional de Cancérologie (ILC), Centre Jean Bernard/Clinique Victor Hugo, Le Mans, France., Muratet JP; Department of Nuclear Medicine, Institut Inter-Régional de Cancérologie (ILC), Centre Jean Bernard/Clinique Victor Hugo, Le Mans, France., Martin E; Radiation Oncology, Centre Georges-Francois Leclerc, Dijon, France., Riedinger AB; Department of Nuclear Medicine, Centre Georges Francois Leclerc, Dijon, France., Kolesnikov-Gauthier H; Department of Nuclear Medicine, Oscar Lambret Center, Lille cedex, France., Dansin E; Department of Radiation Oncology, Oscar Lambret Center, Lille cedex, France., Massabeau C; Département de Radiothérapie. Institut Universitaire du Cancer, Toulouse cedex 9, France., Courbon F; Department of Nuclear Medicine, Institut Claudius Regaud, IUCT, Toulouse cedex 9, France., Farcy Jacquet MP; Department of Radiation Oncology, CHU de Nîmes, Institut de cancérologie du Gard, Rue Henri Pujol, Nîmes, France., Kotzki PO; Department of Nuclear Medicine, Institut régional du Cancer Montpellier (ICM), Montpellier, France.; Department of Nuclear Medicine, CHU de Nîmes, Institut de cancérologie du Gard, Nîmes, France., Houzard C; Department of Nuclear Medicine, Hospices Civils de Lyon, Lyon, France., Mornex F; Department of Radiation Oncology, Hospices Civils de Lyon, Lyon, France., Vervueren L; Department of Nuclear Medicine, CHU Angers, France., Paumier A; Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, site Paul Papin, France., Fernandez P; Department of Nuclear Medicine, Hôpital Pellegrin, CHU de Bordeaux, France; and., Salaun M; Normandy University, UNIROUEN, QuantIF-LITIS EA 4108, Rouen University Hospital, Department of Pulmonology-Thoracic Oncology-Respiratory Intensive Care, Rouen, France., Dubray B; Department of Radiation Oncology and Medical Physics, Henri Becquerel Cancer Center and Rouen University Hospital & QuantIF-LITIS, Rouen, France.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2017 Jul; Vol. 58 (7), pp. 1045-1053. Date of Electronic Publication: 2017 Mar 02.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-5667
DOI:10.2967/jnumed.116.188367